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. A recent claims-based study from Detroit, Michigan, found that warts were more commonly diagnosed in Caucasians (22.6%) than in African Americans (5.7%) (Henderson et al., 2012) . A previous study of the determinants of sexually transmitted infections found that Caucasians were more likely than African Americans to have venereal warts (Short et al., 1984) . Furthermore, a recent prevalence study of warts in Caucasian Dutch schoolchildren aged 4-12 years showed that one-third of the children had warts (van Haalen et al., 2009 ). This suggests that the incidence described in the United States may actually be lower than that in other countries owing to the mixture of racial and ethnic groups in our population.
The strengths of this study include being a large-scale, US populationbased survey with minimal selection bias, and controlling for confounding demographic variables in multivariate models. However, the study also has some limitations. Warts and comorbidities were assessed by caregiver report, which have not been fully validated. The appearance of common warts is reasonably characteristic, and lay recognition can be assumed to be good. Another concern about self/parentalreported warts is potential reporting bias, where subjects with higher socioeconomic status may have better overall health and be more motivated to seek out care for warts. Future studies are needed to validate the accuracy of self/ caregiver report and determine the ideal survey instrument for the epidemiologic study of these disorders.
The peak age of warts occurring at 9-10 years and common presence in teenagers may relate to school attendance and exposures from peer groups. School-and family-based transmissions have been cited as a leading cause of disease (van Haalen et al., 2009) . Agespecific physical activity and sports participation, particularly swimming pool use (Penso-Assathiany et al., 1999) and use of communal showers (Johnson, 1995) , have been linked to transmission of warts. Racial/ethnic and socioeconomic disparities may affect age-specific activities and pool use. Future studies are warranted to determine the role of age-specific physical activities and local environment on the US prevalence of warts. Henderson MD, Abboud J, Cogan CM et al. (2012) Skin-of-color epidemiology: a report of the most common skin conditions by race. Khan et al., 2010) , we conducted a large population-based case-control analysis, including patients with a first-time rosacea diagnosis (index date) between January 1995 and September 2009. We excluded patients with recorded alcoholism (explicit medical Read-code), cancer, or HIV, and patients with o3 years of recorded active history before the index date. Patients with diagnosed rhinophyma or ocular rosacea in the absence of another record of facial rosacea were excluded. We randomly matched one control to each case on age, sex, general practice, calendar time, and number of previous years of history in the database, and applied the same exclusion criteria to controls as to cases. The study protocol was approved by the ISAC (Independent Scientific Advisory Committee) for MHRA (Medicines and Healthcare Products Regulatory Agency) database research. Disease exposure was defined as a DM diagnosis (validity proven elsewhere; Khan et al., 2010; Van Staa and Abenhaim, 1994) before the index date. Among DM patients, we captured the last hemoglobin A1 c (HbA1 c ) value before the index date, stratified into four categories (none, p7.5%, 7.6-10.9%, or X11%). DM duration was stratified into six categories by the number of years between the first recorded prescription of any antidiabetic drug and the index date (no treatment, o1, 1-3, 3-5, 5-10, and 10 þ years), substratified by HbA1 c levels (p7.5% or 47.5%). We analyzed antidiabetic drug use (insulin vs. other antidiabetic drugs) stratified by timing (p or 4180 days before the index date) and duration of use (number of prescriptions before the index date). Within a mutually exclusive drug use model among diagnosed diabetics, we assessed insulin exposure (irrespective of any oral antidiabetic drug (OAD) use) and OAD exposure alone (no insulin exposure at any time), stratified by timing and duration of drug use and by HbA1 c levels. We conducted multivariate conditional logistic regression analyses using SAS statistical software (version 9.3, SAS Institute, Cary, NC), and calculated odds ratios (ORs) with 95% confidence intervals (CIs). We adjusted all ORs for smoking (non, current, ex, unknown), alcohol consumption (0, 1-4, 5-9, 10-14, 15-24, or 25 þ units per week, unknown), and body mass index (BMI, o18.5, 18.5-24.9, 25.0-29.9, or þ 30 kg m À 2 , unknown). Because other potential confounders, i.e., depression, cardiovascular diseases (hypertension, myocardial infarction, hyperlipidemia, heart failure, ischemic heart disease, ischemic stroke/transient ischemic attack), cardiovascular drugs (calcium channel blockers, b-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, statins, acetylsalicylic acid (anticlotting dosage), vitamin K antagonists, and diuretics), systemic steroids, and nonsteroidal anti-inflammatory drugs (NSAIDs) did not alter the relative risk estimates for the association between DM or insulin and rosacea by X10%, we did not include them in the final model.
The study population's demographics and methodology including limitations have been described in detail elsewhere (Spoendlin et al., 2012 Table S2 online). Exposure to any antidiabetic drug was associated with a decreased OR of 0.76 (95% CI 0.71-0.83). The prevalence of insulin exposure was higher in controls (1.1%) than in cases (0.7%), yielding an OR of 0.75 (95% OR 0.65-0.85), unchanged across strata of timing and duration of insulin exposure. OAD exposure was also slightly more prevalent in controls (2.6%) than in cases (2.1%, OR 0.83, 95% CI 0.76-0.91), again independent of timing and duration of drug exposure (Supplementary Table S1 online). The mutually exclusive drug use model (Table 2 ) yielded significantly decreased ORs for insulin users, irrespective of HbA1 c control. OAD use in the absence of insulin was associated with decreased ORs at HbA1 c levels 47.5%, but nonsignificant results at HbA1 c levels p7.5%. Our findings suggest a decreased rosacea risk in DM patients at an advanced disease state, i.e., in patients with high HbA1 c levels and/or long disease duration. The underlying mechanism remains to be clarified; we hypothesize a reciprocal link of the two diseases via the degree of endothelial dysfunction and thus impaired vasodilation. Extrinsic insulin exposure revealed significantly decreased ORs, irrespective of HbA1 c control, whereas OAD use yielded decreased ORs in poorly controlled diabetics only. This might reflect an additional insulin effect on the rosacea risk, but it could also depict a proxy for disease duration and/or severity. As insulin is used in diabetic patients only, we cannot disentangle the role of insulin from the underlying disease within this observational study. Most diabetic patients were coded with a DM subtype-unspecific code (66.6% cases, 68.3% controls), but as ORs were decreased in insulin users and in poorly controlled OAD users, a subtype-independent effect seems likely, especially as endothelial damage and diabetic microvascular complications are presumably driven by shared mechanisms caused by hyperglycemia in both DM subtypes (The Diabetes Control and Complications Trial Research Group, 1993; UKPDS Group, 1998; Browne et al., 2003; Schalkwijk and Stehouwer, 2005; Rask-Madsen and King, 2007; Cade, 2008) . Our study provides evidence for a significantly OADs include biguanides, sulfonylureas, thiazolidinediones, glinides, a-glucosidase inhibitors, and incretin-mimetics.
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Diabetes, Antidiabetics, and Rosacea reduced rosacea risk in diabetics at an advanced disease stage. This is, to our knowledge, a previously unreported finding, but some residual confounding or chance cannot entirely be ruled out. Whether insulin enhances this effect per se or whether it reflects a proxy for disease severity remains unclear.
